Abstract
The aim of the present study was to detect the frequency of monosomy 7 and trisomy 8 in myeloid disorders (acute myeloblastic leukemia (AML), myelodysplastic syndrome (MDS)), their association with GSTT1 and GSTM1 null genotypes, and their prognostic impact. The study included 50 patients with AML and MDS; monosomy 7 and trisomy 8 detection was done by interphase fluorescence in situ hybridization, and glutathione S-transferase (GST) genotyping was done by multiplex PCR. Monosomy 7 was present in 13–30 % of AML and MDS, respectively. A statistically significant relation was found between monosomy 7 and remission failure. Trisomy 8 was found in 10–15 % of AML and MDS. No significant association was found between response to treatment and trisomy 8. There was significant correlation between GSTT1 null/GSTM1 null genotype and poor response to treatment (p < 0.005). There was positive correlation between complete remission and both wild GST genotypes. In the whole patient group, a statistically significant association was found between GSTT null genotypes and monosomy 7 (p = 0.003). No significant association was found between trisomy 8 and specific GST genotypic polymorphism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bernasconi P, Cavigliano PM, Boni M, Calatroni S, Klersy S, Giardini I et al (2003) Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. Leukemia 17:2107–2112
Brozek I, Babinska M, Kardas I, Wozniak A, Balcerska A, Hellmann A, Limon J (2003) Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukemia. J Appl Genet 44:401–412
Byrd JC, Lawrence D, Arthur DC, Pettenati MJ, Tantravahi R, Qumsiyeh M et al (1998) Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from cancer and leukemia group B 8461. Clin Cancer Res 4:1235–1241
Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al (2002) Pretreatment cytogenetic abnormalities are predictive of induction success. Cumulative incidence of relapse and overall survival in adult patients with de novo acute myeloid leukemia results from cancer and leukemia group B (CALGB 8461). Blood 100:4325–4336
Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD et al (1996) Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295–297
Chen Z, Pasquini M, Hong B, Dehart S, Tsai S (2005) The human penumbra gene is mapped to a region on chromosome 7 frequently deleted in myeloid malignancies. Cancer Genetics and Cytogenetics 162:95–98
Cheson BD, Cassileth PA, Head DR et al (1990) Report of the National Cancer Institute-sponsored workshop on definition of diagnosis and response in AML. J Clin Oncol 8:813
Crump C, Chen C, Appelbaum FR, Kopecky KJ, Weiss NS (2000) Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev 9(5):457–460
Dahabreh IJ, Giannouli S, Gota V, Voulgarelis M (2010) GSTT1 and GSTM1 polymorphisms and myelodysplastic syndrome risk: a systematic review and meta-analysis. Int J Cancer 126:1716–1723
Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F et al (1995) Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia 9:1491–1498
Elliott MA, Letendren L, Hanson CA, Tefferi A, Dewald GW (2002) The prognostic significance of trisomy 8 in patients with acute myeloid leukemia. Leuk Lymphoma 43:583–586
Grimwade D, Walker H, Oliver F, Wheatly K, Harrison C, Harrison G et al (1998) The importance of diagnostic cytogenetics on outcome in AML analysis of 1,612 patients entered into the MRC AML to trial. Blood 92:2322
Heba N, Abdelrazik HN, Hala Farawila, Mai sherif, mervat El Ansary (2006) Molecular characterization of chromosome 7 in AML and MDS patients. African Journal of Health Sciences: vol 13, N3-4, 33–42
Heim S, Mitelman F (1992) Cytogenetic analysis in the diagnosis of acute leukemia. Cancer 70:1701
Ketterer B, Taylor J, Meyer D, Pemble P, Coles B, Chulin X et al (1993) Some functions of glutathione transferases. In: Tew KJ, Pickett CB, Mantle TJ, Mannervik B, Hayes JD (eds) Structure and function of glutathione transferases. CRC press, Boca Raton, pp 15–27
Kibbelaar RF, Mulder JWR, Dreef EJ, Klwin (1993) Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Am Soc Hematol
Korke M, Takeuchi S, Yokota J, Park S, Hatta Y, Miller CW, Suruoka N, Koeffler HP (1997) Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer. Genes Chromosomes Cancer 19:1–5
Najfeld V (2012) Conventional and molecular cytogenetic basis of hematologic malignancies. Chapter 55 pp 810–821. In: Hematology basic principles and practice. Churchill Livingstone, Philadelphia
Norppa H, Hirvonen A, Jarventaus H, Uuskula M, Tasa G, Ojajarvi A, Sorsa M (1995) Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human by lymphocytes. Carcinogenesis 16:1261–1264
Ohyashiki K, Sasao I, Ohyashiki JH, Murakami T, Tauchi T, Iwabuchi A et al (1992) Cytogenetic and clinical findings of myelodysplastic syndromes with a poor prognosis. An experience with 97 cases. Cancer 70:94–99
Paulsson K, Sall T, Fioretos T, Mitelman F, Johansson B (2001) The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology. Cancer Genet Cytogenet 130:160–165
Pulsoni A, Pagano L, Latagliate R, Casini M, Cerri R, Crugnola M, De Paoli L, Di Bone E, Invernizzi R, Marmont F, Petti MC, Rigolin G, Ronco F, Spadano A, Tosti E, Visani G, Mandelli F (2004) Survival of elderly patients with acute myeloid leukemia. Haematologica 89:296–302
Rollinson S, Roddam P, Kane E, Roman E, Cartwright R, Jack A et al (2000) Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukemia. Carcinogenesis 21:43–47
Sasai Y, Horiike S, Misawa S, Kaneko H, Kobayashi M, Fujii H et al (1999) Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res 23:975–981
Smith A, Worrillow L, Allan J (2007) A common genetic variant in XPD associates with risk of 5q- and 7q-deleted acute myeloid leukemia. Blood 109(3):1274–1279
Timothy J, Chevassut T, Mufti GJ (2011) The myelodysplastic syndromes. In: Post graduate haematology, 6th edn. Wiley-Blackwell, Oxford, pp 509–510
Voso M, D’ALO F, Putzulu R, Mele L, Leone G (2002) Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood 100:8
Wolman SR, Gundacker H, Appelbaum FR, Slovak ML (2002) Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia. A southwest oncology group study. Blood 100:29–35
Yates JW, Wallace JH, Ellison RR et al (1973) Cytosine arabinoside and Daunorubicin therapy in acute non lymphocytic leukemia (part 1). Cancer Chemoth Rep 57:485
Zhang Y, Yang L, Li R, Zhang L, Zhang MR, Xiao ZJ (2006) The effects of glutathione S-transferase (GSTT1 and GSTM1) genes polymorphisms on treatment efficacy and prognosis of acute myeloid leukemia. Chinese J Intern Med 45:213–216
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ayad, M.W., Nafea, D.A. Glutathione S-transferase genotypes and numerical chromosomal aberrations in myeloid neoplasms. Comp Clin Pathol 23, 1023–1029 (2014). https://doi.org/10.1007/s00580-013-1737-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-013-1737-1